About this trial
The goal of this clinical trial is to learn if a digitalised Exercise Fit Tool (EFT) mobile application can promote physical activity in adolescents aged 12-18 years who have completed treatment for hematologic cancer (e.g., leukaemia and lymphoma). The main questions it aims to answer are:
1. Is it feasible to conduct a larger randomised controlled trial of the digitalised EFT intervention? 2. Does the digitalised EFT intervention improve physical activity levels, physical activity self-efficacy, and quality of life at 6 months?
Researchers will compare the digitalised EFT intervention group to a usual care group to see if the mobile application can promote physical activity levels, physical activity self-efficacy, and quality of life in adolescents with hematologic cancer.Participants will:
1. Receive a 20-minute educational session on how to use the mobile application 2. Use the mobile application to self-assess their appropriate physical activity level and exercise with a virtual coach 3. Complete questionnaires and wear an accelerometer at 1, 3, and 6 months after enrollment 4. Attend a 20-30-minute individual interview at 6 months (intervention group only, 10 participants)
Eligibility criteria
Qualifiers
(1) they are 12-18 years old;
(2) they had been diagnosed with hematologic cancer such as leukaemia and lymphoma;
(3) they are regarded by the responsible physicians as stable, able to conduct PA, and without any PA restrictions,
(4) they completed all cancer treatment;
Disqualifiers
(1) Receiving palliative care
(2) Have physical or cognitive impairment and learning problems as identified from medical records
(3) Identified by physicians that no physical activity should be conducted at the time of recruitment
Trial design
Treatments tested in this trial
- Digitalized Exercise Fit Tool Intervention
- Usual Care